Antidiabetics Market Growth Forecast to 2024: Top Players: Bayer Corporation, Novartis, Johnson & Johnson, AstraZeneca
The Antidiabetics Market is set to exceed USD 110 billion by 2024; according to a new research report by Global Market Insights. Increasing focus on research activities for development of antidiabetics will stimulate antidiabetics business growth during the upcoming years. Adverse events and need for more effective drugs are leading firms to invest more into antidiabetic drugs and antidiabetics delivering devices. For instance, Novo Nordisk is investing heavily on its pipeline drug, Ozempic, for type 2 diabetes in adults. In...
View full press release